In this webinar, Dr. Buckley presents the sex differences in dementia, focusing on diagnosis, tauopathy, and implications for clinical trials.
This presentation highlights the state of play in the literature with regard to sex differences in prevalence and incidence rates of dementia. Dr. Buckley touches upon the well characterized issue of women being underdiagnosed with dementia due to the fact that they perform much better than men on many neuropsychological tests. She presents her work that has shown consistently, and across many independent cohorts, that women show elevated levels of tauopathy in the brain relative to men. After demonstrating these sex differences in these clinical AD-related outcomes, she turns to the question of whether they might be driven by sex steroid hormones or the X chromosome. She ends the talk by touching upon the reasons why we care about sex differences, particularly from a clinical trials perspective. In addition, she presents her working framework for where she thinks the field stands and what gaps remain in the literature.
Key Topics Include:
- The extent to which sex differences exist in Alzheimer’s disease risk
- How sex steroid hormones and the X chromosome play a role in moderating this risk
- Understand the importance of sex disaggregating findings, both in observational research and also in clinical trials
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Resources
Presenters
Associate Professor
Neurology
Massachusetts General Hospital
Dr. Buckley is an Associate Professor of Neurology at Massachusetts General Hospital. She is a recipient of an NIH K99/R00, an NIH DP2 New Innovator Award and an NIH R01. Her research interests lie in sex differences in risk for Alzheimer’s disease and seeking to optimize women’s brain health.
Additional Content From American Physiological Society
Engineering Neuromodulation for Cardiovascular Instability
Dr. Aaron Phillips traces the translational journey of a discovery that began in a foundational laboratory and is now advancing through pivotal clinical trials aimed at stabilizing cardiovascular function.
Skeletal Muscle Circadian Clocks: Keeping Time for Systemic Health
Dr. Karyn Esser presents the critical role of skeletal muscle circadian clocks in maintaining muscle strength, metabolic health, and systemic adaptations to endurance exercise.
Redox Regulation of Skeletal Muscle: A Journey from Liverpool to the International Space Station
Dr. Anne McArdle and Dr. Malcolm Jackson explore groundbreaking research from the Muscle Laboratories at the University of Liverpool. They examine how redox regulation influences the adaptive responses of skeletal muscle during physical activity and how these processes evolve with age.
Additional Content From Society for Women’s Health Research
Hypertension and Hypothalamic Changes in a Mouse Model of Menopause
Dr. Teresa Milner presents research using a mouse model of accelerated ovarian failure to explore estrogen's role in menopausal hypertension, highlighting the therapeutic potential of estrogen receptor beta agonists during menopause transition.
New Treatments for Vasomotor Symptoms Due to Menopause
Dr. JoAnn Pinkerton delves into the vasomotor symptoms associated with menopause, the current understanding of the physiological mechanisms involved, and the pharmacotherapies and treatments available.
Challenges and Opportunities for Treatment of Metastatic Breast Cancer
Join Dr. Marsha Rosner as she explores innovative strategies and novel approaches to tackle the challenges of metastatic triple-negative breast cancer, a particularly aggressive form of cancer affecting a diverse group of women.
Additional Content From Scientist.com
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.
Related Content
Seeing White Matter Aging Through the Visual System
Dr. Janos Groh from the Technical University of Munich explores how the visual system can be used to uncover the cellular, molecular, and neuroinflammatory mechanisms driving white matter aging.
Detecting Early Synaptic Failure in Prion Disease Using Organoid Models
Join our webinar to see how early synaptic dysfunction can be captured with long-term organoid electrophysiology using Mesh MEA.